{
    "code": "02021719",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021719",
    "time": "2020-02-25 12:45:45",
    "許可證字號": "衛署藥輸字第021719號",
    "註銷狀態": "已註銷",
    "註銷日期": "104\/03\/04",
    "註銷理由": "自請註銷",
    "有效日期": "105\/05\/27",
    "發證日期": "86\/05\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202171907",
    "中文品名": "〝維克思丁〞 注射液",
    "英文品名": "VINCRISTINE SULPHATE INJECTION 1MG\/ML",
    "適應症": "急性白血病。",
    "劑型": "270注射劑",
    "包裝": "100支以下盒裝 1公撮、2公撮小瓶",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": [
        ""
    ],
    "藥品類別": "05限由醫師使用",
    "藥品分類": "",
    "主製造廠": {
        "限制項目": "02輸　入",
        "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
        "申請商地址": "新北市淡水區中正東路二段１７７號",
        "主製造廠": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1002000210",
            "成分名稱": "VINCRISTINE SULFATE",
            "含量描述": "",
            "含量": "1.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Vincristine 藥輸021719-103-04-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021719&Seq=001&Type=9"
        }
    ]
}